Literature DB >> 11285967

Systemic vs local administration of delta-aminolevulinic acid for laparoscopic fluorescence diagnosis of malignant intra-abdominal tumors. Experimental study.

J Gahlen1, M Pietschmann, R L Prosst, C Herfarth.   

Abstract

BACKGROUND: Administration of delta-aminolevulinic acid (ALA) either systemically or locally results in tumor-specific accumulation of protoporphyrin IX (PpIX). When excited with light at a defined wavelength and viewed with the appropriate filter cells containing PpIX, have a characteristic red fluorescence. We evaluated both locally (intraperitoneally [i.p.]) and systemically (intravenously [i.v.]) administered ALA to compare its effectiveness for laparoscopic fluorescent visualization of intraperitoneal tumors.
METHODS: Peritoneal carcinosis was induced in rats using colon carcinoma cells (CC531). Photosensitization was achieved either by intravenous (i.v. group) or intraperitoneal (i.p. group) application of ALA solution. Staging laparoscopy was performed in both groups, first using conventional white light and subsequently using blue light (380-440 nm) to excite PpIX-induced fluorescence.
RESULTS: Conventional white light laparoscopy showed 142 visible intraperitoneal tumor foci in the i.p. group and 116 such foci in the i.v. group. In the i.p. group, all tumors (100%) also were fluorescence positive, whereas in the i.v. group only 32 of the tumors (28%) showed the typical red fluorescence. In the i.p. group, 30 additional tumors were detected by fluorescence excitation (21%), as compared with eight additional tumors in the i.v. group (7%).
CONCLUSIONS: Fluorescence laparoscopy after local (i.p.) photosensitization with ALA is a more reliable and effective method than systemic (i.v.) photosensitization for the detection of small or occult i.p. tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11285967     DOI: 10.1007/s004640000243

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  12 in total

1.  5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.

Authors:  S C Chang; G Buonaccorsi; A J MacRobert; S G Bown
Journal:  Lasers Surg Med       Date:  1997       Impact factor: 4.025

2.  [Photodynamic diagnosis of gastrointestinal precancerous lesions after sensitization with 5-aminolevulinic acid. A pilot study].

Authors:  H Messmann; R Knüchel; E Endlicher; T Hauser; R M Szeimies; F Kullmann; W Bäumler; J Schölmerich
Journal:  Dtsch Med Wochenschr       Date:  1998-04-24       Impact factor: 0.628

Review 3.  5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.

Authors:  Q Peng; T Warloe; K Berg; J Moan; M Kongshaug; K E Giercksky; J M Nesland
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

4.  Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues.

Authors:  H Heyerdahl; I Wang; D L Liu; R Berg; S Andersson-Engels; Q Peng; J Moan; S Svanberg; K Svanberg
Journal:  Cancer Lett       Date:  1997-01-30       Impact factor: 8.679

5.  Improving diagnostic staging laparoscopy using intraperitoneal lavage of delta-aminolevulinic acid (ALA) for laparoscopic fluorescence diagnosis.

Authors:  J Gahlen; J Stern; H H Laubach; M Pietschmann; C Herfarth
Journal:  Surgery       Date:  1999-09       Impact factor: 3.982

6.  [Photodynamic therapy of early squamous epithelial carcinomas and severe squamous epithelial dysplasias of the esophagus with 5-aminolevulinic acid].

Authors:  L Gossner; M Stolte; R Sroka; A May; E G Hahn; C Ell
Journal:  Z Gastroenterol       Date:  1998-01       Impact factor: 2.000

7.  Foscan-mediated photodynamic therapy for a peritoneal-cancer model: drug distribution and efficacy studies.

Authors:  R B Veenhuizen; M C Ruevekamp; H Oppelaar; T J Helmerhorst; P Kenemans; F A Stewart
Journal:  Int J Cancer       Date:  1997-10-09       Impact factor: 7.396

8.  Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer.

Authors:  D Fromm; D Kessel; J Webber
Journal:  Arch Surg       Date:  1996-06

9.  Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model.

Authors:  J Bedwell; A J MacRobert; D Phillips; S G Bown
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

10.  Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.

Authors:  C S Loh; A J MacRobert; J Bedwell; J Regula; N Krasner; S G Bown
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

View more
  4 in total

Review 1.  Optical techniques for the molecular imaging of angiogenesis.

Authors:  Michel Eisenblätter; Carsten Höltke; Thorsten Persigehl; Christoph Bremer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

2.  Videoscopic fluorescence diagnosis of peritoneal and thoracic metastases from human hepatoblastoma in nude rats.

Authors:  H Till; F Bergmann; R Metzger; B Haeberle; K Schaeffer; D von Schweinitz; R L Prosst
Journal:  Surg Endosc       Date:  2005-10-03       Impact factor: 4.584

Review 3.  Photodynamic Detection of Peritoneal Metastases Using 5-Aminolevulinic Acid (ALA).

Authors:  Yutaka Yonemura; Yoshio Endo; Emel Canbay; Yang Liu; Haruaki Ishibashi; Akiyoshi Mizumoto; Masamitu Hirano; Yuuki Imazato; Nobuyuki Takao; Masumi Ichinose; Kousuke Noguchi; Yan Li; Satoshi Wakama; Kazuhiro Yamada; Koutarou Hatano; Hiroshi Shintani; Hiroyuki Yoshitake; Shun-Ichiro Ogura
Journal:  Cancers (Basel)       Date:  2017-03-01       Impact factor: 6.639

4.  Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study.

Authors:  F Lüdicke; T Gabrecht; N Lange; G Wagnières; H Van Den Bergh; L Berclaz; A L Major
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.